ArticleBMC infectious diseases2025
Natural history parameters for enteric pathogens to inform modeling studies of diarrhea among children in low-resource settings: results from the MAL-ED longitudinal birth cohort.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPolicy decisions may rely on mathematical modelling to predict intervention impacts. Information for key model parameters is limited for most enteric pathogens. To support informed modeling, we aimed to characterize incidence, severity, and duration for ten enteric pathogens - adenovirus 40/41, astrovirus, Campylobacter jejuni and C. coli, Cryptosporidium, norovirus GII, rotavirus, sapovirus, Shigella, heat-stable enterotoxin-producing enterotoxigenic Escherichia coli (ST-ETEC), and typical enteropathogenic E. coli (tEPEC) - among children aged 2 years or younger in South America, southeast Asia, and sub-Saharan Africa.
methodsWe analyzed stool specimens from MAL-ED, a multisite longitudinal birth cohort with active surveillance of children in South America, southeast Asia, and sub-Saharan Africa. We defined unique infections using longitudinal test results, attributed etiologies to diarrheal episodes, calculated infection rates and disease progression probabilities, and characterized age-based trends.
resultsMost pathogens had peak infection rates around 7 to 9 months of age, with incidence gradually decreasing in the second year of life. In contrast, Cryptosporidium and ST-ETEC incidence plateaued after 9 months of age instead of declining. Shigella incidence continually increased in the first two years of life. The likelihood of developing diarrhea decreased with age for adenovirus 40/41, Campylobacter jejuni and C. coli, and tEPEC. The likelihood of attributable diarrhea becoming severe decreased with age.
conclusionsThe age at peak infection burden and peak disease burden were not necessarily the same for a given pathogen. Each pathogen evaluated had its own distinct age trends. These results could support informed modelling of impacts of interventions for specific enteric pathogens, particularly in low-resource settings. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.